Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.853x

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.84 Million ≈ $-6.96 Million USD) by net assets (AU$11.53 Million ≈ $8.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Imricor Medical Systems Inc stock valuation for the company's overall valuation and market capitalisation.

Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency. See Imricor Medical Systems Inc debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
WHA UTILITIES AND PO
BK:WHAUP-R
0.024x
Zhejiang Giuseppe Garment Co Ltd
SHE:002687
0.041x
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
0.040x
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
-0.053x
Jiangsu Baoli Asphalt
SHE:300135
-0.022x
Jiangsu WELLE Environmental Co Ltd
SHE:300190
0.016x
Longmaster Information Tech
SHE:300288
-0.007x
Icon Offshore Bhd
KLSE:5255
0.083x

Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2025. View IMR stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 AU$11.53 Million
≈ $8.16 Million
AU$-19.75 Million
≈ $-13.97 Million
-1.712x -181.12%
2024-12-31 AU$-7.38 Million
≈ $-5.22 Million
AU$-15.57 Million
≈ $-11.02 Million
2.111x +42.40%
2023-12-31 AU$-8.75 Million
≈ $-6.19 Million
AU$-12.98 Million
≈ $-9.18 Million
1.483x +167.44%
2022-12-31 AU$7.51 Million
≈ $5.31 Million
AU$-16.51 Million
≈ $-11.68 Million
-2.198x -181.58%
2021-12-31 AU$22.40 Million
≈ $15.85 Million
AU$-17.49 Million
≈ $-12.37 Million
-0.781x -83.94%
2020-12-31 AU$28.82 Million
≈ $20.39 Million
AU$-12.23 Million
≈ $-8.65 Million
-0.424x +54.96%
2019-12-31 AU$7.03 Million
≈ $4.98 Million
AU$-6.63 Million
≈ $-4.69 Million
-0.942x -100.20%
2018-12-31 AU$13.47 Million
≈ $9.53 Million
AU$-6.34 Million
≈ $-4.49 Million
-0.471x -143.77%
2017-12-31 AU$-5.25 Million
≈ $-3.72 Million
AU$-5.65 Million
≈ $-4.00 Million
1.075x +6.98%
2016-12-31 AU$-4.03 Million
≈ $-2.85 Million
AU$-4.05 Million
≈ $-2.87 Million
1.005x --

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$469.33 Million
AU$663.30 Million AUD
Market Cap Rank
#12697 Global
#328 in Australia
Share Price
AU$1.85
Change (1 day)
+3.06%
52-Week Range
AU$1.34 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more